Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05686603

Comparison of Picosecond Lasers vs. Ablative Fractional Er:YAG Lasers in Treating Atrophic Scar

Conditions: Acne, Atrophic Scar

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: 1
Phase: NA
Enrollment: 33
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Location: China

Summary

The 1064-nm Nd:YAG picosecond lasers using fractional micro-lens array (P-MLA) was a promising therapy for skin resurfacing. However, no studies have compared P-MLA with ablative fractional 2940-nm Er:YAG lasers (AF-Er) in treating atrophic acne scars. To evaluate the efficacy and safety of P-MLA and AF-Er for the treatment of atrophic acne scars, we performed a prospective, randomized, split-face, controlled trial. Thirty-one Asian patients underwent four consecutive sessions of randomized split-face treatment with P-MLA and AF-Fr at 4-week intervals.

Eligibility Criteria

Inclusion Criteria:age ≥18 years;presence with similar atrophic acne scars on both sides of the face;signed informed consent and cooperated with the follow up and complied the study protocol.Exclusion Criteria:a previous history of keloid or hypertrophic scar formation;undergone any acne scar treatments in the past 6 months before the first treatment;pregnant or lactating females;sensitive to lights;allergic to lidocaine;other preexisting skin conditions or uncontrolled systemic diseases.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05686603). StuddyBuddy aggregates publicly available trial information.